International Society of Nephrology International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic Health.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pecoits-Filho Roberto, Banerjee Debasish, Jardine Meg J, Neuen Brendon, Soler Maria Jose, Ahmed Sofia B, Anderson Lisa J, Bavanandan Sunita, Bansal Shweta, Burton James O, Carrero Juan Jesus, Chang Tara I, Clase Catherine M, Cobo-Marcos Marta, Manzano Alfonso Cueto, de Boer Ian H, Greenwood Sharlene A, Grams Morgan E, Herrington William G, Heerspink Hiddo J L, Jha Vivekanand, Kotwal Sradha S, Kovesdy Csaba P, Krishnasamy Rathika, Levin Adeera, Madero Magdalena, Malik Charu, Mathew Roy O, Michos Erin D, Moorthy Monica, Navaneethan Sankar D, Perkovic Vlado, Rossing Peter, Reusch Jane E B, Robinson Bruce M, Sarnak Mark J, Sloan Lance, Stenvinkel Peter, Taal Maarten W, Tangri Navdeep, Tuttle Katherine R, Viecelli Andrea K, Yee-Moon Wang Angela, Wheeler David C, Wong Michelle M Y, Herzog Charles A, meeting participants
Аннотация
The cardiovascular-kidney-metabolic framework recognizes the interconnected biological, clinical, and societal drivers of cardiovascular disease, chronic kidney disease, diabetes, and obesity. To advance an integrated perspective, aligned with the kidney community focus, the International Society of Nephrology convened an International Expert Forum, bringing together a global and multidisciplinary team of leaders in this field. This meeting report synthesizes key discussions spanning cardiovascular-kidney-metabolic risk stratification, lifestyle interventions, guideline-directed medical therapies, emerging late-stage therapeutics, and models of care delivery. Participants emphasized the importance of early, integrated case finding; long-term, joint kidney-cardiovascular risk assessment; and timely use of evidence-informed therapies to reduce kidney disease progression, kidney failure, and cardiovascular events. Persistent gaps, including therapeutic inertia, fragmented care, and global inequities in access to care, were highlighted, alongside promising multidisciplinary and system-level care models. Emerging therapies targeting residual risk further underscore the need for adaptive implementation strategies. Aligned with the International Society of Nephrology's mission, this forum represents a foundational step toward connecting disciplines, bridging evidence-to-practice gaps, and building global capacity to improve equitable cardiovascular-kidney-metabolic outcomes.